The Journal of Immunology, Vol 147, Issue 8 2493-2499, Copyright © 1991 by American Association of Immunologists

ARTICLES

Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44

BL Rothman, ML Blue, KA Kelley, D Wunderlich, DV Mierz and TM Aune
Institute for Arthritis and Autoimmunity, Miles Research Center, West Haven, CT 06516.

The CD44 molecule, also known as Hermes lymphocyte homing receptor, human Pgp-1, and extracellular matrix receptor III, has been shown to play a role in T cell adhesion and activation. Specifically, anti-CD44 mAb block binding of lymphocytes to high endothelial venules, inhibit T cell-E rosetting, and augment T cell proliferation induced by the CD2 or CD3-TCR pathways. We have characterized an anti-CD44 mAb (212.3) which immunoprecipitates a 90-kDa protein and is specific for CD44 as shown by peptide mapping and antibody competition studies. Interestingly, our studies with 212.3 demonstrate that this CD44- specific mAb completely inhibits T cell proliferation stimulated by the anti-CD3 mAb, OKT3. Inhibition is not a result of reduced cell viability, but is associated with 1) inhibition of IL-2 production, 2) inhibition of IL-2R expression, and 3) inhibition of OKT3-mediated increases in intracellular Ca2+ levels. In addition, 212.3 does not inhibit proliferation by the T cell mitogens PHA or PWM nor does it inhibit proliferation in a mixed lymphocyte reaction. Similar to other anti-CD44 mAb, 212.3 also augments T cell proliferation induced by mAb directed against the T11(2) and T11(3) epitopes of CD2. Thus, these studies describe a novel CD44-specific mAb (212.3) that inhibits T cell activation by OKT3 by blocking early signal transduction. Furthermore, these studies suggest that "receptor cross-talk" between the CD3-TCR complex and CD44 may regulate T cell activation.

This article has been cited by other articles:

				K. Komura, S. Sato, M. Fujimoto, M. Hasegawa, and K. Takehara Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset Rheumatology, October 1, 2002; 41(10): 1149 - 1154. [Abstract] [Full Text] [PDF]

				D. Chen, R. J. McKallip, A. Zeytun, Y. Do, C. Lombard, J. L. Robertson, T. W. Mak, P. S. Nagarkatti, and M. Nagarkatti CD44-Deficient Mice Exhibit Enhanced Hepatitis After Concanavalin A Injection: Evidence for Involvement of CD44 in Activation-Induced Cell Death J. Immunol., May 15, 2001; 166(10): 5889 - 5897. [Abstract] [Full Text] [PDF]

				S. L. Blass, E. Pure, and C. A. Hunter A Role for CD44 in the Production of IFN-{{gamma}} and Immunopathology During Infection with Toxoplasma gondii J. Immunol., May 1, 2001; 166(9): 5726 - 5732. [Abstract] [Full Text] [PDF]

				K. A. Fitzgerald and L. A. J. O'Neill Characterization of CD44 Induction by IL-1: A Critical Role for Egr-1 J. Immunol., April 15, 1999; 162(8): 4920 - 4927. [Abstract] [Full Text] [PDF]

				J. J. Gilbert, T. R. Pettitt, S. D. Seatter, S. D. Reid, M. J. O. Wakelam, and M. M. Harnett Antagonistic Roles for Phospholipase D Activities in B Cell Signaling: While the Antigen Receptors Transduce Mitogenic Signals Via a Novel Phospholipase D Activity, Phosphatidylcholine-Phospholipase D Mediates Antiproliferative Signals J. Immunol., December 15, 1998; 161(12): 6575 - 6584. [Abstract] [Full Text] [PDF]

				Y. Yakushijin, J. Steckel, S. Kharbanda, R. Hasserjian, D. Neuberg, W.-m. Jiang, I. Anderson, and M. A. Shipp A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma Blood, June 1, 1998; 91(11): 4282 - 4291. [Abstract] [Full Text] [PDF]

				B. M. Sandmaier, R. Storb, K. L. Bennett, F. R. Appelbaum, and E. B. Santos Epitope Specificity of CD44 for Monoclonal Antibody-Dependent Facilitation of Marrow Engraftment in a Canine Model Blood, May 1, 1998; 91(9): 3494 - 3502. [Abstract] [Full Text] [PDF]

				A. L. Rothermel and D. C. Altieri High affinity cross-reacting mAb generated by minimal mimicry: Implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression PNAS, March 31, 1998; 95(7): 3816 - 3820. [Abstract] [Full Text] [PDF]

				R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity Blood, September 15, 1997; 90(6): 2217 - 2233. [Abstract] [Full Text] [PDF]

				M. Zoller, A. Schmidt, A. Denzel, and J. Moll Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation Blood, July 15, 1997; 90(2): 873 - 885. [Abstract] [Full Text] [PDF]

				A. Rafi, M. Nagarkatti, and P. S. Nagarkatti Hyaluronate-CD44 Interactions Can Induce Murine B-Cell Activation Blood, April 15, 1997; 89(8): 2901 - 2908. [Abstract] [Full Text] [PDF]